Valid

GB/T 19973.1-2023Sterilization of health care products--Microbiological methods - Part 1: Determination of a population of microorganisms on products (English PDF)

医疗保健产品灭菌微生物学方法第1部分:产品上微生物总数的确定

Preview PDF

This is a limited preview

Buy now to download the full PDF (65 pages)

Need quotation for your management?

Get a formal quotation for GB/T 19973.1-2023 in 30 minutes.

Issued by

SAMR; SAC

Level / Type

National · Recommended

Issue date

March 17, 2023

Implementation date

October 1, 2024

Scope

GB/T 19973.1-2023 is the English-translated version of 医疗保健产品灭菌微生物学方法第1部分:产品上微生物总数的确定.

GB/T 19973.1-2023 is the Chinese standard "Sterilization of health care products--Microbiological methods - Part 1: Determination of a population of microorganisms on products".

Its scope clause reads: This document specifies requirements and provides guidance on the enumeration and microbial characterization of the population of viable microorganisms on or in a health care product, component, raw material or package.

Note 1: The nature and extent of microbial characterization is dependent on the intended use of bioburden data. Note 2: See Annex A for guidance on Clauses 1 to 9.

This document does not apply to the enumeration or identification of viral, prion or protozoan contaminants. This includes the removal and detection of the causative agents of spongiform encephalopathies, such as scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease.

Note 3: Guidance on inactivating viruses and prions can be found in ISO 22442-3, ICH Q5A(R1) and ISO 13022. This document does not apply to the microbiological monitoring of the environment in which health care products are manufactured. Its clauses include terms and definitions.

Found what you need?

Document preview — GB/T 19973.1-2023

National Standard of the People's Republic of China

Issued by: SAMR; SAC

Foreword
Introduction
1 Scope
2 Normative references
3 Terms and definitions
4 General requirements
5 Selection of products
6 Methods of determination and microbial characterization of bioburden
7 Validation of the method for determining bioburden
8 Routine determination of bioburden and interpretation of data
9 Maintenance of the method for determining bioburden
Annex A (Informative) Guidance on the determination of a population of microorganisms on products
Annex B (Informative) Guidance on methods to determine bioburden
Annex C (Informative) Validation of bioburden recovery efficiency
Annex D (Informative) Typical assignment of responsibilities
Bibliography

1 Scope

This document specifies requirements and provides guidance on the enumeration and microbial characterization of the population of viable microorganisms on or in a health care product, component, raw material or package.

Note 1: The nature and extent of microbial characterization is dependent on the intended use of bioburden data.

Note 2: See Annex A for guidance on Clauses 1 to 9.

Note 3: Guidance on inactivating viruses and prions can be found in ISO 22442-3, ICH Q5A(R1) and ISO 13022.

This document does not apply to the microbiological monitoring of the environment in which health care products are manufactured.

2 Normative references

The following documents contain requirements which, through reference in this text, constitute provisions of this document. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any amendments) applies.

ISO 13485 Medical devices - Quality management systems - Requirements for regulatory purposes

Note: YY/T 0287-2017 Medical devices - Quality management systems - Requirements for regulatory purposes (ISO 13485:2016, IDT)

3 Terms and definitions

For the purposes of this document, the following terms and definitions apply.

ISO and IEC maintain terminological databases for use in standardization at the following addresses:

——IEC Electropedia: available at http://www.electropedia.org/;

——ISO Online browsing platform: available at http://www.iso.org/obp.

3.1 batch

defined quantity of a product intended or purported to be uniform in character and quality, which has been produced during a defined cycle of manufacture

[Source: ISO 11139: 2018, 3.21]

3.2 bioburden

population of viable microorganisms on or in product and/or sterile barrier system

[Source: ISO 11139: 2018, 3.23]

3.3 bioburden correction factor

numerical value applied to a viable count to compensate for incomplete removal of microorganisms from a product and/or failure to culture microorganisms

[Source: ISO 11139: 2018, 3.24]

3.4 bioburden estimate

value established by applying a bioburden correction factor to a bioburden count

[Source: ISO 11139: 2018, 3.25] […]

......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 65 pages — is available in the English PDF.

Referenced standards

Normative references

YY/T 0287-2017Medical devices-Quality management systems- Requirements for regulatory purposes

ISO 13485 · ISO 13485.2016

Cited by

How to Download GB/T 19973.1-2023

1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.